key: cord-0862007-t5spncu6
authors: Cervantes-Barragan, Luisa; Vanderheiden, Abigail; Royer, Charlotte J.; Davis-Gardner, Meredith E.; Ralfs, Philipp; Chirkova, Tatiana; Anderson, Larry J.; Grakoui, Arash; Suthar, Mehul S.
title: Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection
date: 2021-05-13
journal: bioRxiv
DOI: 10.1101/2021.05.12.443948
sha: c611c013b721ed14d4948be95e89264c25daeca6
doc_id: 862007
cord_uid: t5spncu6

Infection with SARS-CoV-2 has caused a pandemic of unprecedented dimensions. SARS-CoV-2 infects airway and lung cells causing viral pneumonia. The importance of type I interferon (IFN) production for the control of SARS-CoV-2 infection is highlighted by the increased severity of COVID-19 in patients with inborn errors of type I IFN response or auto-antibodies against IFN-α. Plasmacytoid dendritic cells (pDCs) are a unique immune cell population specialized in recognizing and controlling viral infections through the production of high concentrations of type I IFN. In this study, we isolated pDCs from healthy donors and showed that pDCs are able to recognize SARS-CoV-2 and rapidly produce large amounts of type I IFN. Sensing of SARS-CoV-2 by pDCs was independent of viral replication since pDCs were also able to recognize UV-inactivated SARS-CoV-2 and produce type I IFN. Transcriptional profiling of SARS-CoV-2 and UV-SARS-CoV-2 stimulated pDCs also showed a rapid type I and III IFN response as well as induction of several chemokines, and the induction of apoptosis in pDCs. Moreover, we modeled SARS-CoV-2 infection in the lung using primary human airway epithelial cells (pHAEs) and showed that co-culture of pDCs with SARS-CoV-2 infected pHAEs induces an antiviral response and upregulation of antigen presentation in pHAE cells. Importantly, the presence of pDCs in the co-culture results in control of SARS-CoV-2 replication in pHAEs. Our study identifies pDCs as one of the key cells that can recognize SARS-CoV-2 infection, produce type I and III IFN and control viral replication in infected cells. Importance Type I interferons (IFNs) are a major part of the innate immune defense against viral infections. The importance of type I interferon (IFN) production for the control of SARS-CoV-2 infection is highlighted by the increased severity of COVID-19 in patients with defects in the type I IFN response. Interestingly, many cells are not able to produce type I IFN after being infected with SARS-CoV-2 and cannot control viral infection. In this study we show that plasmacytoid dendritic cells are able to recognize SARS-CoV-2 and produce type I IFN, and that pDCs are able to help control viral infection in SARS-CoV-2 infected airway epithelial cells.

Infection with SARS-CoV-2 in humans has caused a pandemic of unprecedented dimensions. In 61 the United States, more than 31 million people have tested positive for infection and more than 62 550,000 have died as of April 2021. SARS-CoV-2 infects airway epithelial cells and Type 2 63 pneumocytes causing fever, dry cough, and shortness of breath. While most patients experience 64 mild to moderate disease, some progress to more severe disease, including pneumonia and acute 65 respiratory failure. Severe cases of COVID-19 can result in lung damage, low blood oxygen levels, 66 and death 1,2 . 67 68 Type I and III IFNs are a major part of the innate immune defense against viral infections 3 . One 69 characteristic of coronavirus infections including SARS-CoV-2 is the low induction of type I IFN in 70 the host 4-6 . The reduced type I IFN production from infected cells is caused by both lack of 71 recognition of the viral RNA by pathogen recognition receptors, and the IFN antagonist function 72 of several viral non-structural proteins (nsp; as reviewed in 7,8 ). Early reports detected low levels 73 of type I IFN in the blood of COVID-19 patients 4 . However, transcriptional analysis of 74 bronchoalveolar lavage (BAL) or peripheral blood of COVID-19 patients detected an early type I 75 IFN signature 9-11 . The importance of type I IFN production for the control of SARS-CoV-2 infection 76 is highlighted by the increased severity of COVID-19 in patients with inborn errors of type I IFN 77 response, as well as patients presenting with auto-antibodies against IFN-α 12,13 . Moreover, Corning) and cultured until confluent. Specimens were then transferred to an air/liquid interface 146 and differentiated for 2-3 weeks. Cultures were maintained in DMEM/Ham's F-12 medium 147 supplemented with 2% Ultroser G (Pall Corp., France), until all wells had TEER measurements 148 greater than 1000 Ω and deemed ready for use. 149 150 Co-culture of HAE and pDC cells. pDCs were isolated as described above, then stimulated for 151 3 hours in complete RPMI supplemented with; medium, CpG A (ODN2216 at 6g/ml), UV 152 inactivated SARS-CoV-2 (MOI=1) at 37°C. During the 3 hour stimulation, differentiated pHAE 153 cultures were infected; the apical side of the pHAE culture was washed 3 times with PBS, then 154 SARS-CoV-2 (MOI=1) was allowed to adsorb for 1 hour at 37°C. After adsorption, the apical side 155 was washed 3 times with PBS to remove excess virus. The basolateral media was then replaced 156 with fresh media containing the stimulated pDCs, medium only, or IFNβ (100 IU/mL 

are uniquely poised to respond to pathogen infection and produce large amounts of type I IFNs. 207

However, the role of pDCs in responding to SARS-CoV-2 is not well understood. To investigate 208 this, pDCs were isolated from blood of healthy donors and infected with SARS-CoV-2. CpG A 209 (ODN2216 at 6g/ml) was used as control. Following SARS-CoV-2 infection, pDCs produced over 210 3500 pg/ml of IFN-α as early as 24 hours post-infection ( Figure 1A) . To determine if virus 211 replication is required for pDCs to respond to SARS-CoV-2, we stimulated pDCs with either live 212 SARS-CoV-2 or UV inactivated SARS-CoV-2 (UV-SARS-CoV-2) at equivalent MOIs and 213 measured IFN-α production. pDCs maintained IFN-α production after stimulation with UV-SARS-214

CoV-2 as compared to live SARS-CoV-2, demonstrating that virus replication is not required by 215 pDCs for sensing SARS-CoV-2 and to produce type I IFN. CoV-2 to pDCs stimulated with either UV-SARS-CoV-2 or CpG A we confirmed that the type I 231 and III IFN gene expression was similar in all three groups ( Figure 2C and D) . However, there 232 were some DEGs were present only each of the conditions, Interestingly, we also observed an 233 increase in the apoptosis signature in SARS-CoV-2 activated pDCs when compared to medium 234 stimulated pDCs suggesting pDCs may die after activation with SARS-CoV-2 and type I and III 235 IFN production ( Figure 2E) . These results confirm that viral replication is not needed for a high 236 production of type I and type III IFN by pDCs after sensing SARS-CoV-2 infection, and that 237 stimulation with SARS-CoV-2 may increase the apoptosis signature in pDCs. 238

Since pDCs are able to produce type I and III IFN after SARS-CoV-2 stimulation, we next 241 investigated if pDC-derived-IFN is able to control SARS-CoV-2 replication and protect lung 242 epithelial cells. To test this, we utilized pHAE cells isolated from the bronchial or tracheal 243 region of healthy donors. These cells are cultured in an air-liquid interface to create a 244 polarized, pseudostratified epithelial layer that models the critical features of the human 245 respiratory tract, such as cilium movement and mucus production 31 . We have previously 246

shown that pHAE cells are susceptible to SARS-CoV-2 infection, and respond by producing 247 a variety of inflammatory cytokines 35 . However, SARS-CoV-2 infection does not induce the 248 production of type I or type III IFN by pHAE cells. To test if pDCs are able to control viral 249 infection in pHAE cells, we developed a co-culture system. pHAE cells were infected with 250 SARS-CoV-2 at MOI=1 for 1 hour. In parallel, pDCs were stimulated with UV-SARS-CoV-2, 251

CpG A, or left untreated. After 3 hours, pDCs were washed and placed in the bottom well of 252 the SARS-CoV-2 infected-pHAE transwell culture ( Figure 3A) . Addition of recombinant IFN-control. UV-SARS-CoV-2 stimulated pDCs and CpG stimulated pDCs were able to strongly 255 reduce replication and virus production of SARS-CoV-2 in pHAE cells. Co-culture with 256 stimulated pDCs reduced infectious SARS-CoV-2 production (as measured by focus-forming 257 assay) from the apical surface of pHAE cells by 1000-fold, as well as viral RNA (100-fold 258 reduction) at 72h post infection (Figure 3B and C) . Importantly, the protective effect was 259 mediated by pDCs, since addition of CpG or UV-SARS-CoV-2 alone to the basolateral side 260 didn't reduce viral replication. Interestingly, unstimulated pDCs were also able to reduce the 261 viral load, suggesting that infected pHAE cells are able to activate a type I IFN response in 262 pDCs that is rapid enough to decrease viral replication within 72 hours (Figure 3B and C) . 263

As seen in our previous study, addition of IFN- to the bottom well reduced viral replication, 264 confirming its protective effect against SARS-CoV-2 and suggesting pDCs act through type I 265 IFN production. Indeed, when we analyzed the transcriptional profile of infected pHAEs co-266 cultured with pDCs we observed the upregulation of several interferon-stimulated genes 267

(ISGs) such as IFIH1 and IFIT2 ( Figure 3D) . Figure 4C) . Accordingly, heatmap analysis identified an upregulation of many ISGs (IFIT2, RSAD2, ISG20) in IFN-β treated, pDC or UV-CoV-2-pDC 301 co-cultured pHAE cells, with not only higher magnitude but also greater breadth of ISG 302 expression in the pDC co-cultured cells (Figure 4D) . We also analyzed if pDC co-culture 303 affected the inflammatory response induced in pHAE by SARS-CoV2 infection. As seen in 304 figure 4D, co-culture with pDCs increased the inflammatory response of infected pHAE cells. 305

Additionally, co-culture with UV-CoV-2-pDC upregulated the expression of 10 key 306 inflammatory response genes, such as cytokine receptors IL12RB1, IL15RA, CSF3R, that 307 was not observed in untreated, or IFNβ treated pHAE cells. Interestingly, co-culture with pDCs 308 also induced the expression of molecules of the antigen presentation pathway. This may be 309 of particular importance during the initial phases of infection in order harness the adaptive 310 immune response to SARS-CoV-2. SLC1A3  PDGFRL  NKD2  MIR425  MIR147B  IFNW1  IFNL3  IFNL1  IFNB1  IFNA8  IFNA7  IFNA6  IFNA5  IFNA4  IFNA21  IFNA2  IFNA17  IFNA16  IFNA14  IFNA13  IFNA10  IFNA1  IDO1  CXCL11  CXCL10  CEACAM1  CCL8  CCL7  CCL2 

A pneumonia outbreak associated with a new coronavirus of probable bat 465 origin

A Novel Coronavirus from Patients with Pneumonia in China

Shared and Distinct Functions of Type 469 I and Type III Interferons

Imbalanced Host Response to SARS-CoV-2 Drives Development 472 of COVID-19

Interaction of SARS and MERS Coronaviruses with the 476 Antiviral Interferon Response

SARS coronavirus pathogenesis: host innate immune 479 responses and viral antagonism of interferon

To sense or not to sense viral RNA--essentials of coronavirus innate 482 immune evasion

Systems biological assessment of immunity to mild versus 484 severe COVID-19 infection in humans

Single-cell landscape of bronchoalveolar immune cells in patients with 487 COVID-19

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell 489

Autoantibodies against type I IFNs in patients with life-threatening 491 COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening 493 COVID-19

IFN-alpha2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 495 Infected with SARS-CoV-2

Retrospective Multicenter Cohort Study Shows Early Interferon Therapy 498

Is Associated with Favorable Clinical Responses in COVID-19 Patients

Plasmacytoid Dendritic Cells: Development, Regulation, and Function

The multifaceted biology of plasmacytoid dendritic cells

Subsets of human dendritic cell precursors express different toll-like 505 receptors and respond to different microbial antigens

Cutting Edge: TLR-Dependent viral recognition along with type I IFN 508 positive feedback signaling masks the requirement of viral replication for IFN-{alpha} 509 production in plasmacytoid dendritic cells

Control of coronavirus infection through plasmacytoid 512 dendritic-cell-derived type I interferon

Plasmacytoid dendritic cells control T-cell response to 515 chronic viral infection

Time-resolved systems immunology reveals a late juncture linked to fatal 518 COVID-19

Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized 520 Human Airway Epithelium

Type I and Type III Interferons Restrict SARS-CoV-2 Infection of 522

Human Airway Epithelial Cultures

In vivo antiviral host transcriptional response to SARS-CoV-2 524 by viral load, sex, and age

Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and 527 susceptibility to therapies in primary human airway epithelium

SARS-CoV-2 triggers an MDA-5-dependent interferon response 530 which is unable to control replication in lung epithelial cells

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from 533 SARS-CoV

Inhibition of SARS-CoV-2 by type I and type III interferons

An Infectious cDNA Clone of SARS-CoV-2

CX3CR1 is an important surface molecule for respiratory syncytial virus 539 infection in human airway epithelial cells

Chemokines in innate and adaptive host defense: basic 542 chemokinese grammar for immune cells

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-545 dioxygenase in plasmacytoid dendritic cells

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes 548 directly activate mature Tregs via indoleamine 2,3-dioxygenase

Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human 551

Airway Epithelial Cultures

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification 554 via UNC93B and IRAK4

Type I interferon negatively controls plasmacytoid dendritic cell numbers 556 in vivo

Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted 558

Plasmacytoid Dendritic Cells during Chronic Viral Infection

Persistent virus infection 561 inhibits type I interferon production by plasmacytoid dendritic cells to facilitate 562 opportunistic infections